To better understand the role of BMP inhibitors to treat lung cancers, the potency of the BMP receptor inhibitor, DMH2 [16, 31], to decrease the expression of Id1 and its effect on cell growth was examined in a panel of lung cancer cell lines of different cell types and mutations commonly found in lung cancer. Here, ID1 is linked to lung cancer.